1 results match your criteria: "North Carolina gCase Western Reserve University[Affiliation]"
Impact of randomized antiretroviral therapy initiation on glucose metabolism.
AIDS
June 2014
aUniversity of Colorado-Anschutz Medical Campus, Aurora, Colorado bHarvard School of Public Health cBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts dLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance eGilead Sciences, Foster City, California fViiV Healthcare, Research Triangle, North Carolina gCase Western Reserve University, Cleveland, Ohio, USA.
Objective: Prior studies have found that early HIV protease inhibitors contribute to glucose dysregulation. Few randomized trials have evaluated glucose indices in antiretroviral-naive individuals on newer antiretroviral therapy (ART).
Methods: A5224s was a substudy of A5202, a prospective trial of 1857 ART-naive participants randomized to blinded abacavir-lamivudine (ABC/3TC) or tenofovir DF-emtricitabine (TDF/FTC) with open-label efavirenz (EFV) or atazanavir-ritonavir (ATV/r).